DalsnaFinance

Oppenheimer raises Q32 Bio stock price target on trial data to $40

Markets Investing.com By Investing.com 13 Jul 2026 14:24 1 min read
Oppenheimer raises Q32 Bio stock price target on trial data to $40

Oppenheimer raises Q32 Bio stock price target on trial data to $40

Oppenheimer raises Q32 Bio stock price target on trial data to $40

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.